Viewing Study NCT02150967


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-02-20 @ 1:32 PM
Study NCT ID: NCT02150967
Status: TERMINATED
Last Update Posted: 2023-07-03
First Post: 2014-05-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Sponsor: QED Therapeutics, a BridgeBio company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cholangiocarcinoma View
None FGFR2 Gene Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cholangiocarcinoma, View
None FGFR2 gene fusion, View
None FGFR genetic alteration View